These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11366816)

  • 1. ABT-378 early access program begins.
    AIDS Treat News; 1999 Oct; (No 328):1-2. PubMed ID: 11366816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanded access program for ABT-378 under way.
    Slovick J
    Posit Living; 1999 Nov; 8(10):10. PubMed ID: 11367322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABT-387/r early access program expanded further.
    Res Initiat Treat Action; 1999 Dec; 5(5):22. PubMed ID: 11366887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upcoming compassionate use programs for two new antiretrovirals will begin this fall.
    Schouten J
    STEP Perspect; 1999; 99(3):16. PubMed ID: 11366864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ICAAC: new drugs in late breaker session.
    James JS
    AIDS Treat News; 1999 Oct; (No 328):3-5. PubMed ID: 11366817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded access.
    Proj Inf Perspect; 1999 Sep; (28):8. PubMed ID: 11367366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease inhibitors: resistance, resistance, resistance.
    Gilden D; Falkenberg J; Torres G
    GMHC Treat Issues; 1997 Feb; 11(2):5-10. PubMed ID: 11364108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early access program for ABT-378/r.
    Highleyman L
    BETA; 1999; 12(4):3-4. PubMed ID: 11367247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The latest antiviral news.
    Vazquez E
    Posit Aware; 1999; 10(2):44. PubMed ID: 11366851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New antiretroviral drugs part I: PIs.
    Murphy RL
    AIDS Clin Care; 1999 May; 11(5):35-7. PubMed ID: 11367101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stavudine, lamivudine plus novel protease inhibitor therapy in antiretroviral-naive HIV-infected individuals treated for 24 weeks.
    Murphy RL
    Antivir Ther; 1999; 4 Suppl 3():85-7. PubMed ID: 16021877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABT-378/r helpful in failing patients.
    AIDS Patient Care STDS; 2000 May; 14(5):281-2. PubMed ID: 10833817
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug works in treatment-naive, experienced patients.
    AIDS Alert; 1999 Dec; 14(12):136. PubMed ID: 11366988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lopinavir/ritonavir in HIV-infected patient with long-term virological failure: immunovirological response and tolerance in 121 patients of the ANRS CO8 Aproco-Copilote cohort].
    Brunet-François C; Taieb A; Masquelier B; Le Moing V; Lewden C; Dellamonica P; Cuzin L; Allavena C; Spire B; Chêne G; Raffi F;
    Med Mal Infect; 2007 Mar; 37(3):172-7. PubMed ID: 17239554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LaCARP seeks patients for study that will compare protease inhibitors.
    Fac Notes (New Orleans La); 1998; 10(6):6. PubMed ID: 11366144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abbott agrees to implement a compassionate use program for Ritonavir.
    J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):38. PubMed ID: 11362798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of lopinavir/ritonavir for the treatment of HIV-infection.
    Vogel M; Rockstroh JK
    Expert Opin Drug Saf; 2005 May; 4(3):403-20. PubMed ID: 15934849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Are all boosted protease inhibitors the same? Previously treated patients profit too from lopinavir/r].
    MMW Fortschr Med; 2003 Dec; 145(50):61. PubMed ID: 14963981
    [No Abstract]   [Full Text] [Related]  

  • 20. Two-year outcomes of children on non-nucleoside reverse transcriptase inhibitor and protease inhibitor regimens in a South African pediatric antiretroviral program.
    Jaspan HB; Berrisford AE; Boulle AM
    Pediatr Infect Dis J; 2008 Nov; 27(11):993-8. PubMed ID: 18818556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.